Terms: = Breast cancer AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3 AND Treatment
11 results:
1. Gold nanoparticles attenuate the interferon-γ induced socs1 expression and activation of NF-κB p65/50 activity via modulation of microRNA-155-5p in triple-negative breast cancer cells.
Farhana A; Alsrhani A; Rasheed N; Rasheed Z
Front Immunol; 2023; 14():1228458. PubMed ID: 37720228
[TBL] [Abstract] [Full Text] [Related]
2. Harnessing tumorous flaws for immune supremacy: is miRNA-155 the weak link in breast cancer progression?
Sharma S; Opyrchal M; Lu X
J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 36189796
[TBL] [Abstract] [Full Text] [Related]
3. Elucidating the pharmacological mechanism by which Si-Wu-Tang induces cellular senescence in breast cancer via multilevel data integration.
Zhao M; Pan B; He Y; Niu B; Gao X
Aging (Albany NY); 2022 Jul; 14(14):5812-5837. PubMed ID: 35859293
[TBL] [Abstract] [Full Text] [Related]
4. T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses
Klein K; Witalisz-Siepracka A; Gotthardt D; Agerer B; Locker F; Grausenburger R; Knab VM; Bergthaler A; Sexl V
Front Immunol; 2021; 12():650977. PubMed ID: 34248938
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis.
Yang W; Zhou W; Zhao X; Wang X; Duan L; Li Y; Niu L; Chen J; Zhang Y; Han Y; Fan D; Hong L
Hereditas; 2021 Apr; 158(1):15. PubMed ID: 33892811
[TBL] [Abstract] [Full Text] [Related]
6. Nuclear EGFR as a molecular target in cancer.
Brand TM; Iida M; Luthar N; Starr MM; Huppert EJ; Wheeler DL
Radiother Oncol; 2013 Sep; 108(3):370-7. PubMed ID: 23830194
[TBL] [Abstract] [Full Text] [Related]
7. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract] [Full Text] [Related]
8. Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells.
Kuo PL; Ni WC; Tsai EM; Hsu YL
Mol Cancer Ther; 2009 May; 8(5):1328-39. PubMed ID: 19383849
[TBL] [Abstract] [Full Text] [Related]
9. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.
Ryo A; Suizu F; Yoshida Y; Perrem K; Liou YC; Wulf G; Rottapel R; Yamaoka S; Lu KP
Mol Cell; 2003 Dec; 12(6):1413-26. PubMed ID: 14690596
[TBL] [Abstract] [Full Text] [Related]
10. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.
He B; You L; Uematsu K; Zang K; Xu Z; Lee AY; Costello JF; McCormick F; Jablons DM
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14133-8. PubMed ID: 14617776
[TBL] [Abstract] [Full Text] [Related]
11. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2.
Leung KC; Doyle N; Ballesteros M; Sjogren K; Watts CK; Low TH; Leong GM; Ross RJ; Ho KK
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1016-21. PubMed ID: 12552091
[TBL] [Abstract] [Full Text] [Related]
